AVUVA
DEAD

Serial Number

79292795

Owner

Medlink Company for Investment and Commercial Agencies

Filing Date

May 11, 2020

Add to watchlist:

No watchlists yet
View on USPTO

AVUVA Trademark

Serial Number: 79292795

AVUVA is a trademark filed by Medlink Company for Investment and Commercial Agencies on May 11, 2020. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Medlink Company for Investment and Commercial Agencies

25, Michel Bakhoum Street - Dokki

Entity Type: 09

Trademark Details

Filing Date

May 11, 2020

Registration Date

Not Registered

Goods & Services

Non-medicated cosmetics and toiletry preparations, perfumery, essential oils, creams for leather, hair lotions shampoos

Marketing, selling, importing and exporting services in the field of non-medicated cosmetics and toiletry preparations, perfumery, essential oils, creams for leather, hair lotions shampoos

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 12, 2022 FINT
FINAL DISPOSITION NOTICE SENT TO IB
May 20, 2022 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 20, 2022 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 27, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 9, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 9, 2022 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
May 20, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 20, 2021 ABN2
ASSIGNED TO EXAMINER
May 19, 2021 DOCK
REFUSAL PROCESSED BY IB
Oct 19, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 1, 2020 RFCS
REFUSAL PROCESSED BY MPU
Sep 30, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 13, 2020 RFCR
NON-FINAL ACTION WRITTEN
Sep 12, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Sep 8, 2020 MAFR
ASSIGNED TO EXAMINER
Sep 4, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 4, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 3, 2020 REPR